BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 17201664)

  • 21. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against SIV infection in macaques by immunization with inactivated virus from the BK28 molecular clone, but not with BK28-derived recombinant env and gag proteins.
    Mills KH; Page M; Chan WL; Kitchin P; Stott EJ; Taffs F; Jones W; Rose J; Ling C; Silvera P
    J Med Primatol; 1992; 21(2-3):50-8. PubMed ID: 1433267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.
    Cecil C; West A; Collier M; Jurgens C; Madden V; Whitmore A; Johnston R; Moore DT; Swanstrom R; Davis NL
    Virology; 2007 Jun; 362(2):362-73. PubMed ID: 17275057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.
    Korioth-Schmitz B; Perley CC; Sixsmith JD; Click EM; Lee S; Letvin NL; Frothingham R
    Vaccine; 2015 Oct; 33(42):5715-5722. PubMed ID: 26192357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of positive cellular and humoral immune responses by a prime-boost vaccine encoded with simian immunodeficiency virus gag/pol.
    Someya K; Ami Y; Nakasone T; Izumi Y; Matsuo K; Horibata S; Xin KQ; Yamamoto H; Okuda K; Yamamoto N; Honda M
    J Immunol; 2006 Feb; 176(3):1784-95. PubMed ID: 16424209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.
    Zhao J; Lou Y; Pinczewski J; Malkevitch N; Aldrich K; Kalyanaraman VS; Venzon D; Peng B; Patterson LJ; Edghill-Smith Y; Woodward R; Pavlakis GN; Robert-Guroff M
    Vaccine; 2003 Sep; 21(25-26):4022-35. PubMed ID: 12922139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.
    Martins MA; Bonaldo MC; Rudersdorf RA; Piaskowski SM; Rakasz EG; Weisgrau KL; Furlott JR; Eernisse CM; Veloso de Santana MG; Hidalgo B; Friedrich TC; Chiuchiolo MJ; Parks CL; Wilson NA; Allison DB; Galler R; Watkins DI
    PLoS One; 2013; 8(1):e54434. PubMed ID: 23336000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.
    Egan MA; Chong SY; Megati S; Montefiori DC; Rose NF; Boyer JD; Sidhu MK; Quiroz J; Rosati M; Schadeck EB; Pavlakis GN; Weiner DB; Rose JK; Israel ZR; Udem SA; Eldridge JH
    AIDS Res Hum Retroviruses; 2005 Jul; 21(7):629-43. PubMed ID: 16060834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
    Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A
    J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants.
    Nakaya Y; Zheng H; García-Sastre A
    Vaccine; 2003 May; 21(17-18):2097-106. PubMed ID: 12706700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recombinant human adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice.
    Flanagan B; Pringle CR; Leppard KN
    J Gen Virol; 1997 May; 78 ( Pt 5)():991-7. PubMed ID: 9152415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates.
    Santra S; Seaman MS; Xu L; Barouch DH; Lord CI; Lifton MA; Gorgone DA; Beaudry KR; Svehla K; Welcher B; Chakrabarti BK; Huang Y; Yang ZY; Mascola JR; Nabel GJ; Letvin NL
    J Virol; 2005 May; 79(10):6516-22. PubMed ID: 15858035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.
    Patterson LJ; Malkevitch N; Pinczewski J; Venzon D; Lou Y; Peng B; Munch C; Leonard M; Richardson E; Aldrich K; Kalyanaraman VS; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(16):8607-20. PubMed ID: 12885879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus.
    Negri DRM; Borghi M; Baroncelli S; Macchia I; Buffa V; Sernicola L; Leone P; Titti F; Cara A
    J Gen Virol; 2006 Nov; 87(Pt 11):3385-3392. PubMed ID: 17030874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity.
    Crotty S; Lohman BL; Lü FX; Tang S; Miller CJ; Andino R
    J Virol; 1999 Nov; 73(11):9485-95. PubMed ID: 10516057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro.
    Peng Y; Lin FC; Verardi PH; Jones LA; McChesney MB; Yilma TD
    J Virol; 2007 Mar; 81(5):2187-95. PubMed ID: 17166912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
    Wingard JB; Anderson B; Weissman D
    Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge.
    Negri DRM; Baroncelli S; Catone S; Comini A; Michelini Z; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Boros S; Liljestrom P; Norley S; Heeney J; Titti F
    J Gen Virol; 2004 May; 85(Pt 5):1191-1201. PubMed ID: 15105535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.